Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets
Tilray Medical received INFARMED approval to conduct microbiological and chemical/physical quality testing in-house at its EU-GMP-certified Cantanhede, Portugal facility. Bringing testing in-house reduces reliance on third-party labs, lowering batch-release costs and shortening testing timelines from harvest to sale.
Key figures
- Facility
- Cantanhede, Portugal EU-GMP-certified
- Countries served
- more than 20 countries
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.